Mubadala Investment Company, established in 2002 by the Government of Abu Dhabi, serves as a principal agent in the diversification of Abu Dhabi's economy. With a focus on generating sustainable financial returns, Mubadala manages a global portfolio of approximately $229 billion, encompassing a wide range of sectors, including aerospace, information and communication technology, semiconductors, renewable energy, healthcare, and real estate. The company is based in Abu Dhabi, with additional offices in key global cities such as Rio de Janeiro, Moscow, New York, and San Francisco. Mubadala is dedicated to addressing pressing regional needs, particularly in healthcare, while also emphasizing strong governance and responsible investment practices. As a trusted partner and engaged shareholder, Mubadala plays a significant role in fostering economic growth and innovation both locally and internationally.
Senior Vice President - Office of the Chief Corporate and Human Capital Officer
Frederic Lardieg
Partner, Europe Ventures
Shaun Lee
Partner, US Ventures
Ana Mostarac
Partner and Head of Operations
Khaldoon Al Mubarak
CEO
Luke Nicklin
Partner, US Ventures
James Peck
Director
Justin Sabet-Peyman
Executive Director
Hasan Jasem Al Nowais
CEO
271 past transactions
3650 Capital
Funding Round in 2025
3650 Capital is a CRE lending and loan servicing firm.
Imepac
Acquisition in 2025
Imepac offers medical courses and programs that builds knowledge and transform lives.
Deel
Secondary Market in 2025
Deel, Inc., also known as Lets Deel, Inc., is a payroll and compliance platform that simplifies the hiring and management of global remote contractors. Founded in 2017 and headquartered in San Francisco, California, the company offers an integrated platform that combines contracts, payments, and tax compliance into a single interface. This allows businesses to efficiently manage the complexities of hiring international employees while ensuring adherence to local regulations. Deel's services include automated payment processing, invoicing, customer support, and insurance products related to employment. The platform is designed to enhance the experience for both organizations and contractors, streamlining the onboarding process and facilitating seamless payroll operations worldwide.
Auron Therapeutics
Series B in 2025
Auron Therapeutics is a biotechnology company based in Wellesley, Massachusetts, dedicated to developing innovative therapies for cancer. Founded in 2018, the company aims to transform the treatment paradigm by shifting from traditional cell-killing approaches to differentiation therapy, which seeks to convert malignant cells into normal functioning cells. This strategy reactivates the body's inherent cellular programs to promote tumor maturation and restore normal tissue. Auron Therapeutics utilizes advanced platforms that integrate large omic datasets with high-throughput flow cytometry, enabling the rapid identification and validation of multiple therapeutic targets and drugs using primary human patient samples. Through its research, the company aspires to address unmet medical needs in oncology and provide life-saving treatments for cancer patients.
Light Horse Therapeutics
Series A in 2025
Light Horse Therapeutics is the gene editing applied to small-molecule drug discovery, pioneering approaches to target the root causes of disabling and life-threatening diseases. Its advanced platform identifies cryptic chemically accessible functional domains within targets that are critical in disease biology. Our initial focus addresses high-value, historically challenging oncology targets with the opportunity to apply the technology to other therapeutic areas in the future.
Tenvie Therapeutics
Series A in 2025
Tenvie Therapeutics is a biotechnology company founded to improve patients' lives with neurological, cardiometabolic, and ophthalmic diseases. The company is focused on developing small molecules targeting brain inflammation, metabolic dysfunction, and lysosomal issues, with a robust pipeline inherited from Denali Therapeutics. Tenvie is progressing a range of therapeutics aimed at addressing neurological, cardiometabolic, and ophthalmic conditions. Its collection of fully owned, highly brain-penetrant, and precisely designed peripherally restricted small molecules targets three main factors of disease: alleviating inflammation, correcting metabolic dysfunction, and rejuvenating lysosomal function.
Al Ittihad Drug Store
Acquisition in 2024
Al Ittihad Drug Store operates as a distributor specializing in pharmaceutical and consumer healthcare products. The company caters to pharmacies and supermarkets, providing a diverse selection of therapeutic classes that include antibacterial, hypertension, diabetes, cardiovascular, and anticoagulant medications, in addition to medical devices and consumer health products. Al Ittihad Drug Store is committed to addressing the comprehensive healthcare needs of consumers by ensuring timely deliveries, extensive network coverage, competitive pricing, and tailored services.
Global Medical Supply Chain
Acquisition in 2024
Global Medical Supply Chain is a healthcare logistics and medical consumables supply company.
nChroma Bio
Venture Round in 2024
nChroma Bio's integrated product engine allows for safe, accurate, and targeted in vivo administration, addressing major shortcomings of current genetic medicine techniques.
Silver Rock Financial
Private Equity Round in 2024
Silver Rock Financial LP is an employee-owned asset management firm established in December 2015, with its headquarters in Los Angeles, California, and additional offices in New York, Miami, and Santa Monica. The firm specializes in investment management services for pooled investment vehicles, charitable organizations, corporations, and family investment vehicles. Silver Rock employs an opportunistic credit strategy, focusing on global investments in stressed, distressed, and performing credit across the full capital structure, including leveraged loans and high-yield bonds. The firm utilizes fundamental analysis and in-house research to guide its investment decisions and also offers mutual funds to its clients. As a Registered Investment Adviser, Silver Rock Financial is committed to delivering tailored investment solutions.
Zelis
Private Equity Round in 2024
Zelis is a healthcare and financial technology company that specializes in claims cost management and payments optimization solutions. Founded in 2016 and based in Bedminster, New Jersey, Zelis provides integrated services such as network analytics, payment integrity, electronic payments, and claims communications. These offerings aim to streamline the pricing, payment, and explanation of healthcare claims for payers, healthcare providers, and consumers across medical, dental, and workers' compensation markets. By leveraging advanced technology, Zelis assists its clients in navigating the complexities of the healthcare financial landscape while ensuring compliance with evolving regulations. The company is supported by investment firms Parthenon Capital Partners and Bain Capital.
9fin
Series B in 2024
9fin Limited is a London-based company founded in 2016 that specializes in developing artificial intelligence software designed to provide comprehensive financial data for the bond market, particularly focusing on high-yield bonds. The company offers a data analytics platform that utilizes computer vision and machine learning to facilitate the search, filtering, and analysis of financial information. By delivering real-time market news, deal monitoring, and price data presented in chart formats, 9fin supports professionals in finance, investment banking, and asset management in making informed investment decisions. Its tools foster collaboration among teams and assist users in assessing risks effectively, ultimately streamlining the decision-making process in the credit markets.
CI Financial
Acquisition in 2024
CI Financial is an independent firm specializing in wealth and asset management services for both individuals and institutions. The company has a significant presence in the Canadian market, ranking as the second-largest non-bank affiliated asset manager, with substantial assets under management and advisement. CI Financial is known for its adaptive approach to meet the evolving needs of investors, offering a diverse range of investment strategies and services aimed at enhancing client experiences. By combining personalized service with the resources and expertise of a larger organization, CI Financial strives to provide a distinctive wealth management experience that sets it apart in the industry.
Odoo
Secondary Market in 2024
Odoo is an open-source platform that offers a comprehensive suite of integrated business applications aimed at managing various company operations. Its tools encompass customer relationship management (CRM), eCommerce, accounting, inventory management, point of sale, and project management, among others. These applications are designed to work cohesively, facilitating seamless workflows across different departments within a business. Odoo enables organizations to automate processes and monitor activities from any device, thus enhancing efficiency and productivity in managing their operations.
Crusoe Energy Systems
Series D in 2024
Crusoe Energy Systems Inc., based in Denver, Colorado, develops innovative technology and solutions aimed at addressing operational, environmental, and regulatory challenges in the oil and gas sector. Founded in 2018, the company specializes in its Digital Flare Mitigation solution, which allows upstream operators without pipeline access to convert wasted natural gas into electricity for energy-intensive computing. This service not only helps oil and gas producers reduce routine flaring of natural gas but also assists them in achieving regulatory compliance and maintaining production levels amid increasing regulations and pipeline constraints. Crusoe Energy Systems is committed to creating solutions that benefit the environment, local communities, and energy producers alike.
GC Therapeutics
Series A in 2024
GC Therapeutics specializes in synthetic biology to efficiently program patient-derived stem cells into various cell types. The company has developed a proprietary platform that integrates synthetic biology and artificial intelligence, enabling streamlined manufacturing and improved quality of cell therapies. Their approach allows for the rapid differentiation of pluripotent stem cells, creating unique SuperCells™ customized for specific medical conditions. The foundational technology was developed in Professor George Church's lab at Harvard Medical School, and the team at GC Therapeutics comprises dedicated biologists and tissue engineers focused on translating this innovative method into practical therapies for patients.
Flink
Venture Round in 2024
Flink is a Berlin-based company founded in 2020 that specializes in an online platform for grocery delivery services. The company offers a diverse range of grocery products, including fresh herbs, fruits, bread, and essential home supplies. Flink's application allows customers to receive their orders within ten minutes, providing a convenient solution for acquiring everyday necessities while maintaining supermarket pricing. By focusing on quick delivery and a broad selection of items, Flink aims to enhance the shopping experience for consumers seeking efficiency and convenience in their grocery purchasing.
UCB Pharma
Acquisition in 2024
UCB Pharma is a subsidiary of Union Chimique Belge that specializes in neurology and allergies.
Yondr Group
Private Equity Round in 2024
Yondr Group is a developer, owner-operator, and service provider of hyper-scale data centers, addressing the increasing capacity and technical real estate requirements of technology companies. The firm designs, delivers, and operates data center facilities on a global scale, providing clients with tailored, cost-effective solutions that include custom-built rack-ready spaces. Through its comprehensive approach, Yondr Group aims to meet the complex data center capacity demands of businesses in the tech sector.
Outpace Bio
Series B in 2024
Outpace Bio is a biotechnology company that creates smart cell therapies aimed at improving efficacy and safety. It offers a platform that combines custom-designed biological functions with cellular control modalities that program the right response at the right time and place. It creates a mechanism-driven solution tailor-made to improve efficacy and safety. The company collaborates with Lyell Immunopharma to develop and commercialize a potential immune cell therapy for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders, enabling healthcare providers to cure a wide range of diseases as per patient's need.
FirstVet
Series C in 2024
FirstVet is a digital veterinary clinic that offers a video consultation platform to connect pet owners with veterinarians via smartphone, tablet, or computer. Founded in 2016 and headquartered in Stockholm, Sweden, the platform allows users to receive advice on their pets' health and well-being, helping them assess when to seek further care. FirstVet's services include video consultations and medicinal prescriptions, providing a cost-effective and time-efficient alternative to traditional veterinary visits. By leveraging technology, FirstVet aims to enhance pet care and simplify access to veterinary services for pet owners.
Stake
Series A in 2024
Stake is a digital platform that facilitates real estate investment, allowing individuals to invest in income-generating rental properties quickly and easily. The platform aims to modernize real estate investment by making it accessible to a broader audience. Stake achieves this by breaking down properties into smaller, investable shares, thereby enabling users to purchase stakes in residential properties. This approach not only democratizes real estate investment but also enhances transparency and profitability for investors. Through its innovative model, Stake provides a streamlined way for individuals to engage in the real estate market without the complexities traditionally associated with property investment.
Storyblok
Series C in 2024
Storyblok GmbH operates a cloud-based content management platform that enables users to upload, manage, and publish content through its APIs. Founded in 2015 and headquartered in Linz, Austria, Storyblok distinguishes itself with customizable content blocks and visual editing tools, catering to both developers and content editors. Unlike traditional headless content management systems, which may prioritize flexibility for developers, Storyblok emphasizes usability for editors, allowing them to create and manage content without requiring coding skills. The platform includes features such as a visual composer, various content types, and extensive API endpoints for e-commerce, facilitating a seamless user experience while handling complex tasks like order management and multilingual product catalogs.
RelyOn Nutec
Acquisition in 2024
RelyOn Nutec specializes in safety and survival training for the Oil & Gas, Maritime, Offshore Wind, and other high-risk sectors. The company focuses on preventing accidents and injuries by providing comprehensive training in safe conduct, survival skills, competence management, and crisis management. In addition to in-person training sessions, RelyOn Nutec also offers a variety of online courses through its website, catering to the needs of employees in industries that require a heightened emphasis on safety. By equipping clients with essential safety knowledge and skills, RelyOn Nutec helps organizations prioritize employee well-being and operational safety.
Fortress Investment Group
Acquisition in 2024
Fortress Investment Group LLC is a diversified global investment management firm based in New York, founded in 1998. The company specializes in a variety of investment strategies, including private equity, credit, liquid markets, and traditional asset management. It serves over 1,500 institutional investors and private clients worldwide, applying its extensive experience and specialized expertise to identify opportunities across multiple sectors, such as commercial products, food and beverages, information technology, financial services, transportation, energy, infrastructure, and healthcare. Fortress Investment Group is also a Registered Investment Adviser, ensuring compliance with regulatory standards in its investment practices.
Arbol
Series B in 2024
Arbol is a company that operates a climate risk assessment and insurance platform aimed at helping businesses mitigate financial losses from extreme weather events. It connects weather-exposed agricultural entities with capital providers, such as insurers and asset managers, through its innovative insurance marketplace. By utilizing big data, artificial intelligence, and blockchain technology, Arbol enhances transparency and efficiency in managing climate risks. The platform offers parametric insurance solutions that eliminate information asymmetry and lower administrative costs by using objective data from satellites and weather stations. This enables automated pricing and instant payouts based on predefined data triggers, allowing businesses across various sectors to access capital from non-insurance sources and effectively manage their climate-related financial challenges.
Metsera
Series A in 2024
Metsera is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for obesity and metabolic conditions. The company focuses on advancing a variety of oral and injectable treatment options, including incretin, non-incretin, and combination therapies. These treatments are designed to address multiple therapeutic targets, positioning Metsera to meet the evolving demands of the weight loss treatment landscape. Additionally, Metsera integrates proprietary health technology tools to provide personalized care, enhancing the effectiveness of its therapeutic offerings.
Flip
Series C in 2024
Flip is a social shopping app that merges social media and e-commerce, allowing customers to engage with beauty products through video reviews. The platform enables users to discover products via short, user-generated videos, creating a dynamic shopping experience. Customers can receive clothing tailored to their preferences and share their try-on photos within the Flip community, seeking feedback from friends to enhance their decision-making process. By facilitating instant access to a community of shoppers and creators, Flip provides brands with tools to launch social commerce initiatives and connect with potential buyers. The platform emphasizes peer validation, enabling shoppers to make informed purchases with a seamless one-click checkout option.
Avanse Financial Services
Private Equity Round in 2024
Avanse Financial Services Limited is a non-banking financial company based in Mumbai, India, specializing in education financing for students. Established in 1992, the company provides a range of financial solutions including loans for higher education in India and abroad, e-learning initiatives, and vocational training programs. Avanse also offers loans to educational institutions to support their operational and growth needs. The company's goal is to ensure that deserving students have access to affordable financing options to cover course fees and living expenses, without a cap on the loan amount. By leveraging technology, Avanse aims to streamline the loan application process and enhance access to education-related financial support across the entire educational ecosystem, from pre-school to post-graduation.
KELIX Bio
Acquisition in 2024
KELIX Bio is a biopharmaceutical company that specializes in the development and distribution of high-complexity generic medicines, targeting underserved populations in emerging markets, particularly in Egypt and North Africa. The company focuses on differentiated therapeutic areas, including oncology, and aims to enhance the availability and affordability of essential pharmaceuticals in these regions. By leveraging innovation and cost leadership, KELIX Bio seeks to address the challenges faced by healthcare systems in providing access to critical medications, ultimately improving health outcomes for patients in its markets.
Capstan Therapeutics
Series B in 2024
Capstan Therapeutics is a biotechnology company focused on enhancing the therapeutic potential of in vivo RNA-based therapies. It develops proprietary targeted delivery systems, including targeted lipid nanoparticles, to improve the efficacy and control of dosage in engineered cell therapies. This innovative platform aims to address a variety of diseases, particularly in the fields of oncology, fibrosis, and inflammation, where there are significant unmet clinical needs. By advancing precision in vivo cell engineering, Capstan Therapeutics seeks to create transformative therapeutics that can offer new solutions for patients facing these challenging conditions.
Moove
Series B in 2024
Moove is a mobility fintech company focused on providing revenue-based vehicle financing to mobility entrepreneurs across Africa. By leveraging embedded alternative credit-scoring technology, Moove integrates its services within ride-hailing, logistics, and last-mile delivery platforms. This innovative approach allows the company to assess the performance and revenue of mobility entrepreneurs, enabling it to underwrite loans for individuals who have been historically excluded from traditional financial services. Through its unique model, Moove aims to democratize vehicle ownership and enhance access to financial resources for a growing number of mobility operators in the region.
Truist Insurance Holdings
Private Equity Round in 2024
Truist Insurance Holdings is a subsidiary of Truist Financial Corporation and the sixth-largest insurance brokerage.
Unlearn.AI
Series C in 2024
Unlearn.AI, Inc. is a biotechnology company that specializes in developing software tools for clinical research, focusing on improving diagnosis and treatment processes. Based in San Francisco, the company offers solutions such as Clinical Trial Design, which helps define inclusion criteria, endpoints, and study sizes; Synthetic Control Arms, which reduce or eliminate the necessity for concurrent control groups; and Subgroup Analysis, which identifies specific patient subgroups within trial results. Unlearn.AI has pioneered the TwinRCT solution, a digital twin service that leverages machine learning to enhance the efficiency and success rates of clinical trials. This innovative approach creates a prognostic digital twin for each patient, allowing for more precise estimations of treatment effects based on historical data. By integrating machine learning and biostatistics, Unlearn.AI aims to accelerate the clinical trial process, benefiting both patients and pharmaceutical sponsors.
Manipal Hospitals
Secondary Market in 2024
Manipal Hospitals, part of the Manipal Education and Medical Group, is a prominent player in India's healthcare sector, particularly recognized in South India. With a legacy spanning over five decades, it has evolved into the country's third largest healthcare group, operating a network of 15 hospitals and three primary clinics. The organization offers a wide range of multi-specialty healthcare services that cater to both Indian and international patients. Its comprehensive care includes both curative and preventive services, addressing medical issues from minor ailments to complex health challenges. Manipal Hospitals is dedicated to providing quality and affordable healthcare, making it a significant contributor to the healthcare landscape in India and beyond.
Ciitizen
Seed Round in 2023
Ciitizen Corporation is a healthcare technology company based in Palo Alto, California, that operates a digital platform designed to empower patients to collect, organize, and share their personal health information, including genomic data and lab results. Founded in 2017, Ciitizen aims to give individuals control over their complete health records, facilitating the sharing of this information with caregivers, researchers, and other relevant parties. The platform addresses the limitations of existing health data portals, which often provide only minimal information and rely on labor-intensive processes to extract insights from unstructured data. By normalizing diverse health information into actionable formats, Ciitizen enhances transparency and accessibility for patients and healthcare providers alike. The company is led by CEO Anil Sethi and is supported by a prominent investment team.
Andalusia Labs
Series A in 2023
Andalusia Labs is focused on developing essential digital infrastructure tailored for internet markets, particularly in the realm of digital assets. The company offers a comprehensive platform that includes a security solution and risk management infrastructure specifically designed for the blockchain sector. This platform facilitates the management of significant amounts of digital assets, providing innovative companies worldwide with the tools necessary to navigate the complexities of risk associated with digital transactions. Through its offerings, Andalusia Labs aims to enhance the security and efficiency of the digital asset marketplace.
Tabby
Series D in 2023
Tabby Inc. is a financial technology company based in the United Arab Emirates that offers innovative payment solutions for online and offline shopping. The company specializes in a buy now, pay later service, providing consumers in the UAE and Saudi Arabia with flexible payment options. Customers can choose to pay for their purchases either in a single deferred payment or in multiple installments, allowing them to manage their spending and enhance their shopping experience. Through its platform, Tabby aims to reshape the relationship between consumers and money, promoting financial freedom and responsible spending.
Atvos
Secondary Market in 2023
Atvos Agroindustrial S.A. is a Brazilian company based in São Paulo that specializes in the production and commercialization of ethanol, very high polarity (VHP) sugar, and electricity derived from sugarcane biomass. Founded in 2007 and formerly known as Odebrecht Agroindustrial S.A., Atvos offers both anhydrous and hydrous ethanol, positioning itself as a provider of sustainable and renewable energy solutions. The company is currently undergoing reorganization and operates as a subsidiary of State Street Brasil S.A. - Banco Comercial. Through its focus on utilizing sugarcane and biomass, Atvos aims to contribute to cleaner and more responsible energy production.
Rejuveron Life Sciences
Series B in 2023
Rejuveron Life Sciences AG is a biotechnology company based in Zug, Switzerland, founded in 2019. The company focuses on developing and investing in innovative drugs and technologies aimed at promoting healthy aging and extending lifespan. As a fully integrated platform, Rejuveron combines its investment strategies with a commitment to advancing therapies that address age-related conditions, leveraging both scientific research and entrepreneurial initiatives in the life sciences sector.
Aman Resorts
Private Equity Round in 2023
Aman Resorts is a luxury hospitality group that specializes in creating intimate and exclusive guest experiences through its small, high-end hotels and resorts. Each property is designed to harmonize with its beautiful natural surroundings, ensuring privacy and tranquility for guests. The company offers a range of services, including accommodations, dining, spa treatments, and cultural activities, all tailored to enhance the guest experience. Aman New York exemplifies this philosophy by introducing urban residences within a historically significant building, featuring unique layouts and private amenities. This urban expansion showcases Aman's commitment to providing unparalleled luxury in both remote and urban settings, maintaining its reputation for discretion and exceptional service.
Getir
Series F in 2023
Getir is a mobile retailer and technology company based in Besiktas, Turkey, founded in 2015. It specializes in on-demand delivery of fast-moving consumer products, offering a wide range of items including groceries, household essentials, and personal care products. The company serves customers in major Turkish cities such as Istanbul, Izmir, Ankara, Bursa, and Kocaeli, facilitating quick and convenient access to everyday necessities.
Moove
Private Equity Round in 2023
Moove is a mobility fintech company focused on providing revenue-based vehicle financing to mobility entrepreneurs across Africa. By leveraging embedded alternative credit-scoring technology, Moove integrates its services within ride-hailing, logistics, and last-mile delivery platforms. This innovative approach allows the company to assess the performance and revenue of mobility entrepreneurs, enabling it to underwrite loans for individuals who have been historically excluded from traditional financial services. Through its unique model, Moove aims to democratize vehicle ownership and enhance access to financial resources for a growing number of mobility operators in the region.
Georgiamune
Series A in 2023
Georgiamune is an immunotherapy company dedicated to advancing oncology treatments. The firm specializes in next-generation immunotherapeutic and homeostatic therapies aimed at addressing cancer and autoimmune diseases. By focusing on innovative approaches, Georgiamune seeks to enhance patient recovery from cancer, contributing to significant breakthroughs in the field of immunotherapy.
Aligned
Private Equity Round in 2023
Aligned Data Centers is a leading technology infrastructure company offering innovative, sustainable, and adaptive Scale Data Centers and Build-to-Scale solutions for global hyperscale and enterprise customers. Our intelligent infrastructure allows densification and vertical growth within the same footprint, enabling customers to scale up without disruption, all while maintaining industry-leading Power Usage Effectiveness (PUE). By reducing the energy, water and space needed to operate, our data center solutions, combined with our patented cooling technology, offer businesses a competitive advantage by improving sustainability, reliability, and their bottom line.
EpiBiologics
Series A in 2023
EpiBiologics focuses on developing antibody-based targeted therapies aimed at membrane and extracellular proteins that contribute to various diseases. The company utilizes its EpiTAC platform to create therapeutics that degrade these disease-driving proteins, addressing the underlying biology of disorders. By specializing in protein degradation, EpiBiologics enables researchers to manipulate cellular proteostasis, offering potential solutions for a wide range of medical conditions.
CoolIT Systems
Acquisition in 2023
CoolIT Systems Inc., based in Calgary, Canada, specializes in designing, engineering, and manufacturing direct contact liquid cooling technologies for data centers, servers, and desktops. The company offers a variety of cooling solutions, including CPU and GPU coolers, liquid-to-liquid heat exchanges, liquid-to-air heat exchanges, and all-in-one liquid CPU coolers. Its products cater to high-performance computing, cloud, and enterprise markets, serving industries such as finance, oil and gas, research, and big data. CoolIT Systems focuses on delivering next-generation cooling products that meet high standards for reliability and maintenance-free operation, utilizing patented split-flow technologies to enhance rack densities, component performance, and power efficiency. The company collaborates with engineering groups, including AMD, to provide reference cooling solutions for advanced video cards. Founded in 2001, CoolIT Systems continues to innovate in the cooling technology sector both in Canada and internationally.
Matera
Series B in 2023
Matera, a Paris-based company incorporated in 2017, operates an online condominium management platform aimed at simplifying the lives of co-owners. The platform enables residents to effectively manage their buildings by handling administrative and accounting tasks, generating necessary documents and bills tailored to each co-owner's needs. By providing a secure online environment for these functions, Matera allows co-owners to take control of their property management without relying on traditional professional syndicates. Additionally, the platform offers legal and accounting support, further streamlining the management process for building co-owners.
GUODONG GROUP
Venture Round in 2023
GUODONG GROUP is involved in investment, building, operation, maintenance, and communication tower leasing services. They provide comprehensive information infrastructure services. They are engaged in constructing information infrastructure and offering communication services for business users.
TreasurySpring
Series B in 2023
TreasurySpring Limited is a financial technology firm established in 2016 and based in London, United Kingdom. The company operates an online platform designed to connect issuers and investors, with a focus on revolutionizing institutional short-term funding markets. TreasurySpring offers a variety of fixed-term funds, including sovereign funds that invest in government treasury bills and bonds, financial funds providing exposure to investment-grade banking institutions, and corporate funds targeting investment-grade non-financial institutions. The platform employs advanced legal, financial, and operational technologies to create new financial instruments, allowing cash-rich firms to access previously unavailable short-term investments. This innovative approach enables institutions seeking funding to reach a wider array of capital providers while enhancing security and yield.
SHEIN
Venture Round in 2023
SHEIN is an online marketplace that specializes in women's apparel, offering a wide range of fashion items including clothing, shoes, jewelry, and accessories. Founded in 2008 and headquartered in Jiangsu, China, SHEIN operates as an international B2C fast fashion e-commerce platform, serving customers in over 220 countries and regions. The company utilizes on-demand manufacturing technologies to link suppliers with an agile supply chain, effectively reducing inventory waste and allowing for the delivery of a diverse array of affordable products. By focusing on accessibility and affordability, SHEIN aims to make fashion accessible to a global audience.
TIER Mobility
Convertible Note in 2023
TIER Mobility GmbH is a Berlin-based shared micro-mobility provider founded in 2018, specializing in electric kick scooters, e-bikes, and e-mopeds for local commuting. The company aims to transform urban mobility by offering users a convenient way to access light electric vehicles through its application software, which allows them to locate and book available scooters. TIER is dedicated to promoting climate neutrality and reducing urban dependence on cars, contributing to a more sustainable and livable environment. Through its proprietary Energy Network, TIER strives to enhance the efficiency and accessibility of its services, thereby supporting cities in their efforts to improve mobility solutions.
BrightSpeed
Private Equity Round in 2023
BrightSpeed is a broadband and telecommunications services company that serves homes and businesses. The goal of Brightspeed is to advance a society in which both individuals and organizations have access to the connectivity they require to complete important tasks. Brightspeed provides internet services without bundles, annual contracts, or data caps. The company is expanding its fiber network to improve connectivity.
Hasten
Venture Round in 2023
Hasten is a pharmaceutical manufacturing company that integrates R&D, manufacturing, and commercialization, and covers the entire industry chain. They are dedicated to creating China's innovative medical and health company, and they collaborate with key government agencies, medical and health professionals, and industry partners to provide high-quality solutions, build a health management ecosystem, and benefit more patients.
Cube Highways and Infrastructure
Private Equity Round in 2023
Cube Highways and Infrastructure is a Singapore-based company focused on investing in road and highway projects, as well as select other infrastructure sectors in India. The firm operates as an independent and professionally-managed platform, utilizing the extensive transportation experience of its management and execution teams. Cube Highways manages and invests in toll-road and highway projects, aiming to enhance India's infrastructure sustainably through improved materials and technology.
Outpace Bio
Series A in 2023
Outpace Bio is a biotechnology company that creates smart cell therapies aimed at improving efficacy and safety. It offers a platform that combines custom-designed biological functions with cellular control modalities that program the right response at the right time and place. It creates a mechanism-driven solution tailor-made to improve efficacy and safety. The company collaborates with Lyell Immunopharma to develop and commercialize a potential immune cell therapy for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders, enabling healthcare providers to cure a wide range of diseases as per patient's need.
EpiBiologics
Series A in 2023
EpiBiologics focuses on developing antibody-based targeted therapies aimed at membrane and extracellular proteins that contribute to various diseases. The company utilizes its EpiTAC platform to create therapeutics that degrade these disease-driving proteins, addressing the underlying biology of disorders. By specializing in protein degradation, EpiBiologics enables researchers to manipulate cellular proteostasis, offering potential solutions for a wide range of medical conditions.
JD Digits
Series B in 2023
JD Digits is a technology company that focuses on integrating digital solutions with financial and physical industries to enhance internet connectivity, digitization, and economic growth. The company offers a range of financial services, including consumer and business loans, asset management, payment solutions, and crowdfunding. Its business lines encompass supply chain finance, consumer finance, insurance, and securities. JD Digits also operates a cloud computing platform that utilizes advanced technologies such as data analytics, artificial intelligence, the Internet of Things, and blockchain to deliver tailored financial services and investment management solutions. By leveraging these technologies, the company aims to provide individuals and businesses with secure and high-yield financial options, fostering financial development and industrial upgrades.
Chroma Medicine
Series B in 2023
Chroma Medicine is a genomic medicine company founded in 2021 and based in Cambridge, Massachusetts, specializing in epigenetic editing. The company is pioneering a new class of genomic therapies aimed at revolutionizing the treatment of genetically driven diseases. By utilizing epigenetics, which is the natural mechanism for gene regulation, Chroma Medicine develops programmable epigenetic editors that target specific genes and modulate chromatin conformation. This innovative approach enables healthcare providers to achieve precise control of gene expression, offering a promising therapeutic option for conditions linked to genetic anomalies.
TIER Mobility
Venture Round in 2023
TIER Mobility GmbH is a Berlin-based shared micro-mobility provider founded in 2018, specializing in electric kick scooters, e-bikes, and e-mopeds for local commuting. The company aims to transform urban mobility by offering users a convenient way to access light electric vehicles through its application software, which allows them to locate and book available scooters. TIER is dedicated to promoting climate neutrality and reducing urban dependence on cars, contributing to a more sustainable and livable environment. Through its proprietary Energy Network, TIER strives to enhance the efficiency and accessibility of its services, thereby supporting cities in their efforts to improve mobility solutions.
Truist Insurance Holdings
Secondary Market in 2023
Truist Insurance Holdings is a subsidiary of Truist Financial Corporation and the sixth-largest insurance brokerage.
Precision Neuroscience
Series B in 2023
Precision Neuroscience is a company focused on developing advanced brain-computer interface technology aimed at offering innovative treatments for the approximately one billion individuals worldwide affected by neurological disorders. Founded in 2021 and based in New York, the company's technology is characterized by its minimally invasive design, safety for removal, and capacity for processing substantial data. This platform enables medical professionals to establish a direct connection between the human brain and artificial intelligence, potentially transforming the landscape of neurological care.
Paradigm
Series A in 2023
Paradigm is rebuilding the clinical research ecosystem by developing a platform that allows all patients equitable access to trials while improving trial efficiency and lowering barriers to participation for healthcare providers. It is an innovative company that is dedicated to transforming the clinical research ecosystem. Their mission is to create a more accessible and equitable healthcare system by developing a platform that enables patients from diverse backgrounds to participate in clinical trials. Clinical trials are essential for testing and developing new drugs, therapies, and medical devices, but historically, they have been plagued by inefficiencies, barriers to access, and inequities in patient representation. Paradigm aims to solve these challenges by creating a platform that uses technology and data-driven insights to streamline the clinical trial process, making it more efficient, cost-effective, and inclusive. The Paradigm platform is designed to facilitate seamless communication and collaboration among all stakeholders involved in clinical research, including patients, healthcare providers, pharmaceutical companies, and regulatory agencies. By leveraging technology such as AI, machine learning, and predictive analytics, Paradigm can identify and match eligible patients to clinical trials, streamline the recruitment and enrollment process, and provide real-time data insights to all stakeholders. Overall, Paradigm's innovative approach to clinical research has the potential to revolutionize the healthcare industry by improving patient outcomes, reducing healthcare costs, and accelerating the development of new treatments and therapies.
Tabby
Series C in 2023
Tabby Inc. is a financial technology company based in the United Arab Emirates that offers innovative payment solutions for online and offline shopping. The company specializes in a buy now, pay later service, providing consumers in the UAE and Saudi Arabia with flexible payment options. Customers can choose to pay for their purchases either in a single deferred payment or in multiple installments, allowing them to manage their spending and enhance their shopping experience. Through its platform, Tabby aims to reshape the relationship between consumers and money, promoting financial freedom and responsible spending.
Dental Care Alliance
Acquisition in 2023
Dental Care Alliance, LLC, based in Sarasota, Florida, offers comprehensive dental support services to dental practices across several states, including Florida, Georgia, Illinois, Indiana, Maryland, Michigan, Pennsylvania, and Virginia. Founded in 1991, the company provides a range of management services designed to alleviate the administrative burdens faced by dental professionals. These services include financial management, billing, recruiting, marketing, and staff training, enabling dentists to focus more on patient care and less on day-to-day operations. By promoting clinical autonomy and enhancing career satisfaction, Dental Care Alliance supports both the professional growth of dental teams and the overall well-being of patients. The company operates various Dental Centers, providing tailored management and administrative support to ensure efficient practice operations.
Resilience
Private Equity Round in 2023
Resilience is a technology-driven biomanufacturing company focused on transforming the production of complex medicines, including biologics, vaccines, nucleic acids, and cell and gene therapies. The company aims to enhance access to these advanced treatments by establishing a sustainable network of end-to-end manufacturing solutions that facilitate rapid, safe, and scalable production. Resilience supports its partners throughout the drug development process, offering customized manufacturing capabilities that cater to the unique requirements of biopharmaceuticals, from pre-clinical stages to commercial supply. By fostering innovation in biopharmaceutical manufacturing, Resilience enables clients to concentrate on breakthrough discoveries that improve patient outcomes while also ensuring the resilience of biopharmaceutical supply chains against potential disruptions.
Upstream Health
Series B in 2023
Upstream Health, founded in 2018 and based in North Lincolnshire, United Kingdom, specializes in developing innovative technologies and service approaches for health and social care teams. The company leverages artificial intelligence alongside a mobile and analytics platform to promote a preventive care model. By focusing on an "upstream" strategy, Upstream Health aims to enhance citizen outcomes and improve patient care through its electronic medical record innovation technology. The team comprises experienced technologists and health service innovators dedicated to addressing the evolving needs of the health and social care systems.
ACTIVE Al Maryah
Venture Round in 2023
ACTIVE Al Maryah is a sports and recreation company that specializes in the construction and management of both indoor and outdoor sports facilities. The company operates a multi-sport venue designed to promote an active lifestyle, offering well-maintained courts for various sports including football, padel, and tennis. With a focus on exceptional service, ACTIVE Al Maryah provides a welcoming environment for individuals and families, encouraging community engagement and healthy living throughout the year.
ACX
Convertible Note in 2022
AirCarbon Exchange, based in Singapore, operates a blockchain-based platform designed for trading carbon commodities, including carbon credits generated by various mitigation projects. The exchange facilitates both spot and futures markets, catering to industry stakeholders managing their carbon liabilities. Supported by the Sustainable Energy Association of Singapore and the Digital Exchange Association, AirCarbon tokenizes carbon offsets into three distinct asset classes: the AirCarbon CORSIA Token for offsets compliant with ICAO guidelines, the AirCarbon Forestry Token for offsets from forest management projects, and the AirCarbon Premium Token for high-quality offsets that align with the United Nations Millennium Development Goals. Additionally, AirCarbon manages an investment fund that provides development capital to carbon sequestration initiatives, generating liquidity in the carbon market and enhancing trading volume. The platform aims to streamline trading processes and support the transition to a carbon-constrained economy while contributing to verified projects that reduce atmospheric carbon.
Vevo Therapeutics
Seed Round in 2022
Vevo Therapeutics is a biotechnology startup focused on improving drug discovery through its Mosaic in vivo drug discovery platform and advanced AI algorithms. The company aims to enhance treatment options for a broader patient population by integrating in vivo data with artificial intelligence to identify more effective drug targets. This innovative approach captures the in vivo context of diseases with single-cell precision, addressing the limitations of traditional in vitro assays. By better representing patient diversity in drug responses, Vevo Therapeutics seeks to reduce the failure rate of drugs in clinical trials, ultimately leading to more successful therapeutic outcomes.
UpStream Care
Series B in 2022
UpStream Care is a primary care services and technology company providing physicians with support and systems. It allows physicians to focus on what they and their patients value the most. Their intelligent technology platform, which integrates with all physician EMRs and provides an elegant workflow for all care coordination activities, augments this in-person clinical support.
ACX
Private Equity Round in 2022
AirCarbon Exchange, based in Singapore, operates a blockchain-based platform designed for trading carbon commodities, including carbon credits generated by various mitigation projects. The exchange facilitates both spot and futures markets, catering to industry stakeholders managing their carbon liabilities. Supported by the Sustainable Energy Association of Singapore and the Digital Exchange Association, AirCarbon tokenizes carbon offsets into three distinct asset classes: the AirCarbon CORSIA Token for offsets compliant with ICAO guidelines, the AirCarbon Forestry Token for offsets from forest management projects, and the AirCarbon Premium Token for high-quality offsets that align with the United Nations Millennium Development Goals. Additionally, AirCarbon manages an investment fund that provides development capital to carbon sequestration initiatives, generating liquidity in the carbon market and enhancing trading volume. The platform aims to streamline trading processes and support the transition to a carbon-constrained economy while contributing to verified projects that reduce atmospheric carbon.
Ramp Network
Series B in 2022
Ramp Network is a fintech startup founded in 2017 by Przemek Kowalczyk and Szymon Sypniewicz, headquartered in Warsaw, Poland. The company focuses on developing payment infrastructure that bridges the gap between cryptocurrency and traditional finance. Its mission is to create a seamless connection between the open blockchain financial system and conventional banking, eliminating the need for a trusted third party. Ramp Network's platform is designed for a variety of clients, including enterprises, gaming companies, non-fungible token marketplaces, decentralized finance projects, and digital wallets. This integration enables these businesses to facilitate fiat-to-crypto transactions for their users, allowing for efficient contract execution and the locking of digital assets within their operations.
Juvena Therapeutics
Series A in 2022
Juvena Therapeutics, Inc. is a biopharmaceutical company based in San Mateo, California, founded in 2017. The company specializes in developing protein-based therapeutics aimed at promoting tissue rejuvenation and addressing age-related diseases in the elderly. Its innovative platform focuses on discovering novel therapeutics that restore cellular functions, targeting conditions such as sarcopenia, wound healing, and neural regeneration. By decoding secreted proteins, Juvena Therapeutics aims to provide solutions for chronic and rare diseases, enhancing the quality of life for aging populations.
Recursion Pharmaceuticals
Post in 2022
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company based in Salt Lake City, Utah, that focuses on revolutionizing drug discovery through the integration of advanced technologies such as artificial intelligence, automation, and bioinformatics. Founded in 2013, the company has developed a comprehensive drug discovery platform that includes various tools and software, such as ReChem for chemical compound design, ReScreen for managing complex experimental workflows, and RePredict for modeling drug relationships using machine learning. These innovations enable Recursion to generate extensive biological and chemical datasets, facilitating the exploration of foundational biology and accelerating the development of new therapeutic solutions. Through its unique approach, Recursion aims to significantly enhance patient outcomes and streamline the drug discovery process.
TruFoodMfg
Acquisition in 2022
TruFoodMfg specializes in contract manufacturing, focusing on private-label nutrition bars, protein bars, chocolate molded products, and baked goods. The company serves a diverse clientele by distributing its products through various retail channels, including club stores, grocery outlets, drug stores, convenience stores, and department stores across the globe.
GlobalConnect
Secondary Market in 2022
GlobalConnect is a prominent alternative provider of fiber network, data center, and managed hosting services in Northern Europe, primarily focusing on Denmark and Germany. Established in 1998 by Niels Zibrandtsen, the company operates a 12,500 km optical fiber network and manages approximately 13,000 square meters of data center space. GlobalConnect offers a range of services including bandwidth connectivity, colocation, and cloud infrastructure, catering to both enterprises and consumers. With a workforce of over 200 employees, the company is dedicated to delivering fast and reliable networking solutions, enhancing connectivity and technological capabilities for its clients across Sweden, Norway, Denmark, Finland, and Northern Germany.
Neumora Therapeutics
Series B in 2022
Neumora Therapeutics operates as a clinical-stage biotechnology company pioneering precision medicines for brain diseases through the integration of data science and neuroscience.
CERC Central de Recebíveis
Venture Round in 2022
CERC Central de Recebíveis S.A. is a financial technology company based in São Paulo, Brazil, that specializes in enhancing the use of receivables in credit operations. Founded in 2015, CERC has developed an intelligent platform designed to provide security and efficiency for lenders utilizing receivables as collateral. The company aims to transform the credit market by facilitating accelerated and sustainable credit growth for businesses of various sizes. By focusing on improving the infrastructure surrounding credit transactions, CERC seeks to increase the overall reliability of receivable-based lending.
Alloy Therapeutics
Series D in 2022
Alloy Therapeutics is a biotechnology company based in Waltham, Massachusetts, founded in 2017. The company focuses on democratizing access to essential drug discovery platforms and services, primarily through its Alloy-Gx platform. This innovative platform features a royalty-free suite of immunocompetent transgenic mice that facilitate in vivo human antibody discovery. Alloy Therapeutics has developed humanized transgenic antibody discovery technology, which offers broad, non-exclusive access to drug discovery tools, allowing scientists to engage in their antibody projects more efficiently and effectively. The company's mission is to enhance the drug discovery process by providing accessible and advanced resources for researchers in the field.
Pretzel Therapeutics
Series A in 2022
Pretzel Therapeutics is a biotechnology company focused on developing therapies for mitochondrial dysfunction. Founded by leading experts in mitochondrial biology, the company aims to create innovative treatments that address the underlying causes of mitochondrial issues. By leveraging a comprehensive understanding of mitochondrial mechanisms, Pretzel Therapeutics seeks to reverse dysfunction at its roots, potentially providing effective solutions for patients suffering from a range of conditions, including those related to aging. The company's name reflects its scientific focus on the mitochondrion, which is characterized by its unique and highly folded inner membrane, distinguishing it from other organelles in the body.
TruKKer
Series C in 2022
TruKKer is a technology-enabled truck aggregator based in Abu Dhabi, UAE, founded in 2016. The company operates a logistics and fleet management platform that simplifies road freight and logistics operations by integrating demand and supply for land freight services. TruKKer's platform connects shippers and carriers in real time, ensuring maximum utilization of available trucks and reducing overall transportation costs. The company's network, powered by real-time data analytics, enhances reliability and transparency while creating opportunities for data monetization and consolidated procurement. By offering end-to-end coverage and a comprehensive service portfolio, TruKKer facilitates cross-border transportation services for various end markets, benefiting both shippers and transporters alike.
Canada Cartage
Acquisition in 2022
Canada Cartage is a provider of outsourced fleet solutions that offers dedicated equipment and drivers to businesses of all sizes. The company specializes in trucking, warehousing, and logistics services tailored for sectors such as grocery, food, retail, and e-commerce. Its offerings include dedicated contract transportation, general freight, fulfillment, and distribution services, as well as home delivery of large format goods. By integrating managed transportation and warehousing solutions, Canada Cartage aims to address complex logistics challenges and enhance operational efficiency for its clients.
Spotnana
Series B in 2022
Spotnana is a travel platform that aims to modernize the infrastructure of the travel industry, enhancing the experience for both corporations and consumers. Its innovative Travel-as-a-Service platform simplifies and reduces costs associated with travel, while also modernizing the way travel suppliers manage and sell their inventory. By doing so, Spotnana enables companies to offer superior global travel experiences to their customers, fostering transparency and trust in the travel process. The platform is designed to connect people and make travel more accessible and efficient for everyone.
Auron Therapeutics
Series A in 2022
Auron Therapeutics is a biotechnology company based in Wellesley, Massachusetts, dedicated to developing innovative therapies for cancer. Founded in 2018, the company aims to transform the treatment paradigm by shifting from traditional cell-killing approaches to differentiation therapy, which seeks to convert malignant cells into normal functioning cells. This strategy reactivates the body's inherent cellular programs to promote tumor maturation and restore normal tissue. Auron Therapeutics utilizes advanced platforms that integrate large omic datasets with high-throughput flow cytometry, enabling the rapid identification and validation of multiple therapeutic targets and drugs using primary human patient samples. Through its research, the company aspires to address unmet medical needs in oncology and provide life-saving treatments for cancer patients.
Flip
Series B in 2022
Flip is a social shopping app that merges social media and e-commerce, allowing customers to engage with beauty products through video reviews. The platform enables users to discover products via short, user-generated videos, creating a dynamic shopping experience. Customers can receive clothing tailored to their preferences and share their try-on photos within the Flip community, seeking feedback from friends to enhance their decision-making process. By facilitating instant access to a community of shoppers and creators, Flip provides brands with tools to launch social commerce initiatives and connect with potential buyers. The platform emphasizes peer validation, enabling shoppers to make informed purchases with a seamless one-click checkout option.
Xilis
Series A in 2022
Xilis, Inc. is a biotechnology company based in Chapel Hill, North Carolina, founded in 2019. It specializes in developing advanced organoid technologies aimed at guiding precision therapy for cancer patients and enhancing drug discovery processes. The company's flagship platform, XilisµO, facilitates rapid diagnostics and personalized drug screening while providing scalable, patient-derived models for high-throughput drug discovery. This technology supports physicians and pharmaceutical companies in creating tailored treatments by enabling effective drug screening, ultimately contributing to more precise and cost-efficient cancer therapies.
Wefox
Series D in 2022
Wefox is an insurtech platform that connects insurance companies, brokers, businesses, and customers to facilitate access to digital insurance solutions. Operating as a digital insurance company, Wefox sells its products through intermediaries rather than directly to consumers, which broadens its market reach. The platform provides a variety of services, including policy management, claims settlement, and quotations for multiple types of insurance, such as health, liability, and disability. By offering a comprehensive suite of tools, Wefox aims to deliver personalized and suitable coverage options to its users, enhancing the overall insurance experience.
Klarna
Venture Round in 2022
Klarna Inc. is an e-commerce payment solutions platform that facilitates cashless transactions for both merchants and shoppers. Founded in 2005 and headquartered in Columbus, Ohio, with additional offices in New York City, Klarna operates as a subsidiary of Klarna Bank AB. The company provides a range of payment options, including direct payments, pay-after-delivery choices, and installment plans, enabling customers to select their preferred payment method. Known for its "buy now, pay later" model, Klarna offers interest-free financing for retail purchases, enhancing the shopping experience. Additionally, the Klarna app provides users with flexible payment options and cashback rewards, while the platform supports in-store, mobile, and online payments, along with services for deliveries and returns.
Proximie
Series C in 2022
Proximie Inc. is a health technology company based in Bedford, Massachusetts, that specializes in a telehealth platform designed for virtual surgical assistance. Founded in 2016 by Nadine Hachach-Haram, Proximie's platform enables surgeons to remotely observe and guide complex surgical procedures using augmented reality, artificial intelligence, and machine learning. This technology allows expert surgeons to connect with their peers globally, sharing knowledge and skills in real-time, regardless of their physical location. The platform is adaptable, compatible with various devices and software used in operating rooms, and can function effectively even in low bandwidth environments. Proximie aims to enhance surgical practices by democratizing access to expert guidance and fostering collaboration among medical professionals.
Juni
Series B in 2022
Juni is a fintech company that offers a banking app and platform tailored for e-commerce and online marketing entrepreneurs. The platform provides an integrated payment solution that allows users to track all their financial activities from a centralized dashboard, giving them a comprehensive overview of their bank accounts, networks, and payment services. By delivering detailed customizable financial reports, Juni empowers digital entrepreneurs to make informed decisions and effectively scale their operations, maximizing the potential of their digital commerce ventures.
Medicina UniFTC
Acquisition in 2022
UniFTC Medicine is designed to train complete doctors and doctors, who will act in an efficient and humanized way, having technologies as an ally. It is Medicine transforming your future for you to transform the future of the world.
Unesulbahia
Acquisition in 2022
Unesulbahia is located in Eunápolis and currently offers nine undergraduate courses: Medicine, Biomedicine, Nursing, Pharmacy, Physiotherapy, Dietetics and Law. Unesulbahia are permanently enhanced through the Structuring Teaching Center, a group made up of 16 medical professors with renowned academic background and extensive professional experience.
Apex Group
Private Equity Round in 2022
Apex Group is a global financial services provider headquartered in Hamilton, Bermuda, founded in 2003. It offers a comprehensive range of services to asset managers, capital markets, private clients, and family offices. By continually evolving its capabilities, Apex has established itself as a single-source solution in the industry, providing services that include fund administration, digital onboarding, depositary and custody services, and business services such as human resources and payroll. The company also offers innovative ESG Ratings and Advisory services tailored for private companies. With a strong global presence, Apex Group is committed to meeting the diverse needs of its clients through a broad spectrum of products and services.
SpotOn
Series F in 2022
SpotOn is a technology company founded in 2017 by Doron Friedman, Matt Hyman, and Zach Hyman, headquartered in San Francisco, California. The company specializes in providing innovative software and payment solutions tailored for small and midsize businesses. SpotOn offers a comprehensive, cloud-based platform that includes tools for payments, point-of-sale systems, marketing, website development, online ordering, appointments, eCommerce, digital loyalty, and review management. By integrating these services, SpotOn aims to enhance operational efficiency and customer engagement for its clients. The company's mission is to empower businesses by delivering high-quality solutions at fair prices, supported by personalized local service.
Storyblok
Series B in 2022
Storyblok GmbH operates a cloud-based content management platform that enables users to upload, manage, and publish content through its APIs. Founded in 2015 and headquartered in Linz, Austria, Storyblok distinguishes itself with customizable content blocks and visual editing tools, catering to both developers and content editors. Unlike traditional headless content management systems, which may prioritize flexibility for developers, Storyblok emphasizes usability for editors, allowing them to create and manage content without requiring coding skills. The platform includes features such as a visual composer, various content types, and extensive API endpoints for e-commerce, facilitating a seamless user experience while handling complex tasks like order management and multilingual product catalogs.
HiveMQ
Series A in 2022
HiveMQ specializes in providing a robust MQTT (Message Queuing Telemetry Transport) platform that facilitates the connection, communication, and management of IoT data in demanding real-world environments. The platform serves various industries, including automotive, energy, logistics, smart manufacturing, and transportation, offering flexibility, security, and scalability for mission-critical applications. Prominent companies such as Audi, BMW, Honeywell, Mercedes-Benz, and Siemens utilize HiveMQ to enhance their IoT projects, modernize manufacturing processes, and improve customer experiences. By enabling architects and developers to effectively implement IoT solutions, HiveMQ positions itself as a trusted standard in the enterprise sector.
Unlearn.AI
Series B in 2022
Unlearn.AI, Inc. is a biotechnology company that specializes in developing software tools for clinical research, focusing on improving diagnosis and treatment processes. Based in San Francisco, the company offers solutions such as Clinical Trial Design, which helps define inclusion criteria, endpoints, and study sizes; Synthetic Control Arms, which reduce or eliminate the necessity for concurrent control groups; and Subgroup Analysis, which identifies specific patient subgroups within trial results. Unlearn.AI has pioneered the TwinRCT solution, a digital twin service that leverages machine learning to enhance the efficiency and success rates of clinical trials. This innovative approach creates a prognostic digital twin for each patient, allowing for more precise estimations of treatment effects based on historical data. By integrating machine learning and biostatistics, Unlearn.AI aims to accelerate the clinical trial process, benefiting both patients and pharmaceutical sponsors.
Tata Power Renewable Energy
Post in 2022
Tata Power Renewable Energy is a Mumbai-based company focused on the development, construction, and operation of renewable energy assets, specifically in the wind and solar power sectors. Recently established as a separate entity from Tata Power, it has inherited control over 720 MW of operational capacity and has an additional 250 MW currently under construction. The company aims to enhance its portfolio through potential equity investments and acquisitions, positioning itself strategically within the renewable energy market.
Welcome Tech
Venture Round in 2022
Welcome Tech is a platform focused on supporting the 250 million global immigrant communities by connecting them with essential information, products, and services. The company serves over 9 million immigrants annually and has nearly 2 million active users. By utilizing a data-driven approach, Welcome Tech offers tailored solutions across various sectors, including finance, education, healthcare, telecommunications, and government services. Founded by experts in immigration and technology, the platform employs proprietary data and recommendation algorithms to deliver relevant services that empower immigrant families. Headquartered in Los Angeles, California, Welcome Tech aims to help immigrants become informed, confident, and active participants in their new communities.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.